Project Serotonin Launches Precision Gut Health Protocol with Smiles Institute of Gastroenterology

Hyderabad: Project Serotonin, a trailblazing preventive healthtech company, has officially launched its specialized Gut Health Protocol, marking a significant expansion of its AI-driven precision health platform. Designed to tackle the genetic and biomarker-driven root causes of digestive conditions, this new offering is set to transform how gut health is managed in India. The Smiles Institute of Gastroenterology in Bengaluru, under the expert clinical leadership of founder Dr. CM Parameshwara, has become the first institution to integrate this protocol directly into its patient care pathways.

This development signifies a shift from traditional, reactive treatments toward a more proactive, personalized approach. By leveraging an eighth-generation AI/ML platform, the protocol analyzes a comprehensive set of variables, including an individual’s genetic predispositions, blood and urine biomarkers, dietary habits, and lifestyle factors. Rather than merely managing symptoms, the system provides precise, corrective interventions in nutrition and supplementation that address the underlying biological drivers of gut-related issues. This integrated strategy functions as a powerful therapy adjunct, allowing clinical institutions to provide a data-driven layer of optimization that evolves alongside the patient’s recovery journey. With gut health imbalances frequently linked to wider issues such as immune function, mental health, and skin vitality, this precision-first model offers a more holistic and measurable way to manage digestive wellness for the long term.